Introduction {#Sec1}
============

Outbreaking in December 2019, the epidemic related to the new coronavirus of severe acute respiratory syndrome (SARS-CoV2), identified in the city of Wuhan, Hubei Province in China, is now spreading around the world \[[@CR1]\]. Although most often responsible for mild symptoms, the infection, also called COVID-19, can cause severe pneumonia \[[@CR2]\]. Patients hospitalized for respiratory distress due to COVID-19 can develop multiple complications, including coagulation disorders. This is linked both to the conditions of prolonged bed rest and to the coagulopathy caused by the infection \[[@CR3]\] with a major thromboembolic risk (deep vein thrombosis (DVT) and pulmonary embolism (PE)) \[[@CR4]\]. Several cases of PE were thus reported and diagnosed through CT angiography \[[@CR5]\].

It is in this context that the ventilation/perfusion single-photon emission computed tomography combined with computed tomography (V/Q SPECT/CT) can be used to search for a pulmonary embolism complication in patients with COVID-19 pneumonia.

We retrospectively present here five cases of V/Q SPECT/CT performed in patients with COVID-19, referred for worsening of dyspnea or chest pain raising suspicion of PE. They benefited from their V/Q SPECT/CT between April 2 and April 10, 2020, in the nuclear medicine departments of the Centre Cardiologique du Nord and of the Delafontaine hospital in Saint-Denis, Ile-de-France, France.

Methods {#Sec2}
=======

V/Q scans were performed using hybrid SPECT-CT cameras (GE Optima NM/CT 640 and GE Discovery; GE Healthcare) with injection of Technetium ^99m^Tc macro-aggregated albumin for the perfusion and inhalation of either ^81m^Kr-Krypton or Technegas® for the ventilation.

Specific protocol and circuit for COVID-19 patients had been implemented:Precautions before performing V/Q SPECT/CT:

V/Q SPECT/CT were all performed on a time slot dedicated to COVID-19 positive patients, at the end of the day. No more non-COVID patients were present in the department, and no examination was scheduled at the same time or after. No more than two COVID patients per day.

The patients did not station in the hallways and wore a mask on arrival in the department.2.Preparation of the examination room:

We had established a delimitation with "clean areas" and "contaminated areas" in contact with the patient. Material unnecessary for the exam was removed from the room. The bin for contaminating objects was placed at the entrance of the room. The room and the equipment were decontaminated before and after each patient.3.Dressing of the personnel:

The personnel had to wear high-protection clothing combining an FFP2 mask, a disposable overcoat, overshoes, a cap, protective glasses, and two pairs of non-sterile gloves. Protective clothing was changed after each patient. One manipulator was in charge of the console, and another one was in contact with the patient.4.Perfusion:

A syringe of Technetium ^99m^Tc macro-aggregated albumin (^99m^Tc-MAA) was prepared just before the patient arrived and then injected in the supine position to avoid sedimentation of macroaggregates into the lung bases. The doses injected depend on the ventilation tracers used: 185 MBq for Krypton and 240 MBq for Technegas®.5.Ventilation:Krypton 81 m

We used a new ventilation kit with disposable masks and tubes. The kit includes a disposable filter between the mask and the tubing set containing a bidirectional membrane to prevent cross-contamination. According to the supplier, the filter is supposed to be 99.9% effective in stopping bacteria and viruses. After the filter, a tube with two-way valves directs, on the one hand, the flow of Krypton air from the generator to the patient and, on the other hand, the exhaled air from the patient's lungs to the ventilation unit. This part of the tubing set is also for single use and was changed after each patient.b.Technegas®

Gas particles were inhaled through a hose and a mouthpiece containing a filter. The mouthpiece and filter were disposable and changed between each patient. A suction bell was located above the patient to prevent the spread of aerosols. Hose disinfection was realized before and after each patient.6.CT parameters:

The following scanner settings were applied: 120 keV/148 mAs, spacing 1.25 mm, 512 × 512 matrix.7.Room disinfection:

Application of a decontaminant on the examination table, the machine, and the patient's environment, leaving to act for 15 min after each patient.

Results {#Sec3}
=======

Case 1 (Fig. [1](#Fig1){ref-type="fig"}) {#Sec4}
----------------------------------------

The first case was a 53-year-old man with dyspnea, tachycardia (heart rate (HR) 120 bpm), and a typical electrocardiographic appearance of S~1~Q~3~ with extended S wave in lead I and Q wave in lead III. Clinical parameters and laboratory data of the patient are available on Table [1](#Tab1){ref-type="table"}.Fig. 1**a** Sagittal fused perfusion SPECT and CT (240 MBq of Pulmocis®). **b** Sagittal fused ventilation SPECT and CT (148 MBq of Technegas®). **c** Sagittal CT scan. Perfusion defect with pleural triangular base of the apical segment of the right lower lobe (white arrow) with normal ventilation in correspondence (white dotted arrow). CT scan shows sub-pleural ground glass predominant in the lower lobes (black arrow)Table 1Clinical and laboratory data of the five patientsPatientsCase 1Case 2Case 3Case 4Case 5Age (years)5371634069SexManManManManWomanIndication of V/Q SPECT/CTDyspnea TachycardiaDyspnea under oxygen therapyDyspnea under oxygen therapyDyspneaTachycardiaChest painDyspnea under oxygen therapyIndication for V/Q SPECT/CT instead of CT angiographyAKI on CKIAKIDisponibility of the scintigraphyLow probability of PELow probability of PEDiagnosis of COVID-19PCR positiveClinical and CT scan findingsPCR positivePCR positivePCR positiveDays of hospitalization13542011Anticoagulant therapyPreventiveNoneNonePreventivePreventiveD-dimers (μg/mL)Not available\> 20,000Not available907330DVT (Venous Doppler US of lower limb or clinical suspicion)No clinical suspicionNo clinical suspicionVenous Doppler US negativeNo clinical suspicionVenous Doppler US negativeOxygen therapyNo15 L15 L4 L2 LClinical parametersSpO~2~98%97%82%95%96%HR120 bpm100 bpm100 bpm90 bpm87 bpm*AKI* acute kidney injury, *CKI* chronic kidney injury, *SpO*~*2*~ oxygen saturation, *HR* heart rate, *PCR* polymerase chain reaction technique, *US* ultrasound

V/Q SPECT/CT found a segmental pulmonary embolism with a mismatch perfusion defect of the apical segment of the right lower lobe, representing an amputation of the total pulmonary vascular bed of approximately 5%.

CT scan showed moderate COVID-19 pulmonary involvement (25--50% of total volume), mainly consisting of subpleural ground glass and rare interlobular reticulations. These areas of hyperdensity, few in number, appeared correctly perfused, and ventilated.

Case 2 (Fig. [2](#Fig2){ref-type="fig"}) {#Sec5}
----------------------------------------

The second case was a 71-year-old man with an increase of dyspnea under oxygen therapy. On arrival in the nuclear medicine department, the HR was 100 bpm and the oxygen saturation under 15 L per minute at 97%. Laboratory test showed a significant increase in D-dimers (\> 20,000 μg/mL). All the clinical parameters and laboratory data of the patient are available on Table [1](#Tab1){ref-type="table"}.Fig. 2**a** Sagittal CT scan. **b** Sagittal fused perfusion SPECT and CT (240 MBq of Pulmocis®). **c** Sagittal perfusion SPECT. **d** Sagittal fused ventilation SPECT and CT (148 MBq of Technegas®). **e** Sagittal ventilation SPECT. Hypoperfusion zone (white arrow) associated with a complete and very extensive ventilatory defect in the apical segment of the right lower lobe (white dotted arrow) corresponding on the CT scan to an alveolar filling zone. In some areas of pulmonary parenchyma relatively preserved on the CT scan, there is an accumulation of Technegas® achieving an aspect of "luxury ventilation" (white arrowhead)

The V/Q SPECT/CT did not find PE.

Ventilation was very heterogeneous: (1) the hyperdensities areas related to COVID-19 pneumonitis on the CT scan were clearly hypoventilated in scintigraphy with several large ventilatory defects, and (2) there was an accumulation of Technegas® in healthy parenchyma zones.

Compared to ventilation, the perfusion was well preserved; however, (1) it was partially reduced in the areas of ground glass, and (2) hypoperfusion seemed to be more pronounced in areas of denser parenchymal consolidation in accordance with large ventilatory defects.

In this patient, CT scan showed a critical extent of COVID-19 pulmonary involvement (\> 75% of total volume).

Case 3 (Fig. [3](#Fig3){ref-type="fig"}) {#Sec6}
----------------------------------------

The third case was a 63-year-old man referred for worsening of respiratory symptoms under oxygen therapy. On arrival in the nuclear medicine department, the patient had an episode of desaturation to 82% under 15 L per minute of oxygen using a high concentration mask. His heart rate was 100 bpm.Fig. 3**a** Axial fused perfusion SPECT and CT (185 MBq of Pulmocis®). **b** Axial Perfusion SPECT. **c** Axial fused ventilation SPECT and CT (148 MBq of Krypton®). **d** Axial Ventilation SPECT. **e** Axial CT scan V/Q SPECT/CT April 3. **f** Axial CT scan April 1. Matched defects (white arrows), dominated by ventilatory anomalies, are located in areas of parenchymal consolidation on the CT scan. There is an accumulation of the perfusion tracer (white dotted arrow) and also of the ventilation tracer (white arrow head) in adjacent healthy parenchyma areas. CT scan shows an increase of the extent of the COVID-19 lesions, now critical (\> 75% of the total volume). Note the cystic areas (black arrow)

Clinical parameters and laboratory data of the patient are available on Table [1](#Tab1){ref-type="table"}.

The V/Q SPECT/CT did not find PE. Ventilation showed very large defects in the subpleural areas and at the bases, corresponding to COVID-19 pulmonary lesions on the CT scan.

In comparison, the perfusion was relatively well preserved, especially in the areas of consolidation. There were rare defects matched in ventilation and perfusion within the lesions of consolidation. However, in those mixed defects areas, ventilation anomalies were predominant. Note as in the previous case the uptake not only of the ventilation tracer but also of the perfusion tracer in the healthy parenchyma areas.

The CT scan showed an aggravation of the pulmonary lesions in comparison with the CT scan performed 2 days earlier, on April 1, with a critical pulmonary involvement (\> 75% of the parenchyma versus 25--50% previously). Faced with the worsening of COVID-19 pneumonia, the patient was transferred to intensive care following the completion of his V/Q SPECT/CT.

Case 4 (Fig. [4](#Fig4){ref-type="fig"}) {#Sec7}
----------------------------------------

The fourth case was a 40-year-old man presenting dyspnea with a saturation of oxygen at 95% under 4 L of oxygen, associated with tachycardia at 90 bpm and right lower chest pain.Fig. 4**a** Axial fused perfusion SPECT and CT (240 MBq of Pulmocis®). **b** Axial fused ventilation SPECT and CT (148 MBq of Technegas®). **c** Axial perfusion SPECT. **d** Axial ventilation SPECT. **e** Axial CT scan. Matched defect in perfusion and ventilation of the posterior segment of the right upper lobe (white arrow), compared to an alveolar filling (black arrow) on the scanner

Clinical parameters and laboratory data of the patient are available on Table [1](#Tab1){ref-type="table"}.

The V/Q SPECT/CT did not find PE. There was a heterogeneous perfusion with partial hypoperfusion zones and complete perfusion defects perfectly consistent with ventilation. These matched defects correspond to pulmonary lesions such as consolidations and organized pneumonitis.

CT scan showed a moderate extent of COVID-19 pulmonary involvement (25--50% of total volume) predominant in the lower lobes.

Case 5 (Fig. [5](#Fig5){ref-type="fig"}) {#Sec8}
----------------------------------------

The fifth case was a 69-year-old woman with persistent dyspnea on oxygen therapy. On arrival in the department, the patient was under 2 L of oxygen with an oxygen saturation at 96% and a HR at 87 bpm.Fig. 5**a** Axial fused perfusion SPECT and CT (185 MBq of Pulmocis®). **b** Axial fused ventilation SPECT and CT (148 MBq of Krypton®). **c** Axial CT scan. Mismatched ventilatory defect in the posterior segment of the right upper lobe (white arrow), compared to ground glass on the scanner (black arrow)

Clinical parameters and laboratory data of the patient are available on Table [1](#Tab1){ref-type="table"}.

V/Q SPECT/CT did not find PE. The perfusion was generally homogeneous and preserved. Pure ventilation anomalies were observed with respect to subpleural ground glass areas. The extent of pulmonary involvement of COVID-19 lung disease on the CT scan was moderate (25--50% of total volume) mainly consisting in ground glass opacity.

Discussion {#Sec9}
==========

Infection with SARS-CoV2 renamed COVID-19 by the World Health Organization (WHO) \[[@CR1]\] is now a pandemic responsible for severe respiratory problems. Soon, the various acute complications impacting the prognosis of hospitalized patients were described, including coagulopathy \[[@CR3]\]. Indeed, coagulation disorders are common in respiratory tract infections and have been identified in other SARS viruses \[[@CR6]\]. In the same way, during the SARS-Cov2 infection, an important inflammatory syndrome can be observed with the production of pro-inflammatory cytokines and activation of the coagulation factors causing a state of hypercoagulation \[[@CR7]\]. A significant increase of D-dimers and fibrin degradation products, suggesting hyperfibrinolysis, has also been observed and associated with a poor prognosis \[[@CR8]\].

Moreover, patients hospitalized for COVID-19 pneumonia often have, in addition to bed rest and sepsis, intrinsic risk factors for thromboembolic disease (obesity, high age).

The diagnosis of thromboembolic disease therefore seems essential in the management of the patient.

COVID-19 is also associated with a significant risk of renal failure \[[@CR9]\], which may contraindicate the injection of iodinated contrast agent on the CT scan as well as the allergy to iodinated contrast agents. In this case, pulmonary scintigraphy becomes the examination of choice for diagnosing PE.

In the five cases of COVID-19 patients that we have reported, we note different patterns and characteristics of the V/Q SPECT/CT:The pulmonary lesions of COVID-19 did not interfere with the diagnosis of thromboembolic disease.The areas affected by COVID-19 on the CT scan were most often responsible for ventilatory defects with a relatively preserved perfusion, little or not diminished, particularly at an early stage of the disease with only ground glass opacities.At an advanced stage of pneumonia, associating alveolar fillings and parenchymal anomalies of organized pneumopathy, the perfusion seemed more damaged with perfusional defects matched in ventilation.

There are several hypotheses regarding these areas of hypoperfusion:An adaptive mechanism with hypoxic pulmonary vasoconstriction and redistribution of the perfusion in adjacent well-ventilated areas \[[@CR10]\].A destructive mechanism, with the occurrence of an alveolar destruction with involvement of the capillary walls, damaging the perfusion. At this stage, we can assume the onset of a pulmonary fibrosis which could also lead to an alteration of the perfusion.An embolism mechanism, with the occurrence of pulmonary infarction in areas of consolidation \[[@CR11]\]. This hypothesis is unlikely since in patients with these patterns, no other embolic signs were found (no mismatched perfusion defects find on the V/Q SPECT/CT).4)Areas of healthy parenchyma on the CT scan had an uptake of the tracers of perfusion (toggle of flow) and ventilation ("luxury ventilation"---in Technegas® and in Krypton) probably related to an adaptive mechanism and a redistribution of the perfusion and ventilation towards the healthy parenchyma.

The nuclear physician will have to pay attention to the technical parameters of the V/Q SPECT/CT, in particular to the scanner settings, which may be able to detect a progression of COVID-19 lesions compared to previous examinations.

Recently, publications came out discouraging nuclear medicine physicians to use ventilation due to the risk of aerosol contamination \[[@CR12]\]. However, to date, no case of cross-contamination has been described with the use of Krypton and Technegas®. The French Society of Nuclear Medicine (SFMN) recommends maintaining V/Q scan with the ventilation to search for PE. According to its recommendations, the risk of contamination is extremely low \[[@CR13]\]. Hygiene measures are obviously needed to limit the risk for healthcare workers as well as for patients (protective clothing, separate COVID+/COVID− circuits, cleaning of rooms, and equipment between each examination) \[[@CR14]\].

Furthermore, performing a V/Q scan without ventilation might decrease its specificity and provide a risk of false-positives \[[@CR15]\]. In the current context of a pandemic, utility of ventilation data must be studied in an appropriate research with a retrospective interpretation of the V/Q SPECT/CT by two readers: one using perfusion and ventilation for diagnosing PE and the other using only perfusion and the CT scan, in order to have more information on the most efficient and secure method for diagnosing PE in COVID-19 patients.

V/Q SPECT/CT not only is a tool allowing the diagnosis of pulmonary embolism in a single modality, but it can also, with the associated CT scanner, assess the degree of pulmonary involvement of COVID-19 while avoiding the risk of renal failure linked to the injection of iodinated contrast medium particularly to patients at risk.

Continuing to collect data will confirm the different patterns highlighted on the scintigraphy. In addition, in this pandemic context and facing a significant infectious risk, the utility of ventilation will also have to be specified.
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